Mbs review Taskforce Newsletter Message from the Chair



Download 20.98 Kb.
Date04.05.2017
Size20.98 Kb.
#17347

mbs review taskforce newsletter

MBS Review Taskforce Newsletter

Message from the Chair

photo of bruce robinson

Welcome to the fourth issue of the Medicare Benefits Schedule (MBS) Review Newsletter.

I’m very pleased to report that the first tranche of clinical committees are finalising their initial recommendations, and in some cases, focusing on MBS items where they see the need for improvements and where there are wide variations in practice.

The first committees include Ear, Nose and Throat (ENT) surgery; Obstetrics; Thoracic Medicine; and Gastroenterology. Their recommendations will be available for public consultation.

The Diagnostic Imaging and Pathology committees will continue through the year as they represent a very large component of MBS items.

Following the commencement of the second tranche of committees (see below) we expect that around 20 more clinical committees plus additional working groups will review MBS services relevant to their disciplines.

I expect that we will have more than 500 clinicians directly involved in the review – and I’m extremely pleased to see such engagement and commitment from the profession.

I’m also pleased that health consumers are contributing to the deliberations of the Review through participation in clinical committees, the Taskforce, as well as consultation forums. The insights and experiences of patients, and their carers, will help us discontinue low-value care and ensure that high-value services underpin the Medicare Benefits Schedule.

Bruce Robinson

Clinical committee update


The first committees will soon finalise their recommendations and release for public consultation. Here are some of the items being considered.

  • Diagnostic Imaging CC has set up working groups on knee imaging, imaging for pulmonary embolism and DVT, bone densitometry, and nuclear medicine.

  • The ENT committee has completed its priority review of tonsillectomy, adenoidectomy and grommet surgery.

  • Gastroenterology has prioritised reviews of colonoscopies, Upper GI endoscopy and capsule endoscopies.

  • The Obstetrics Committee is reviewing the items to align better with clinical practice and eliminating ambiguous item descriptors.

  • Sleep studies and Spirometry are the priority reviews for the thoracic Medicine Committee.

Appropriate Use Criteria


The Taskforce considered a paper by Professor Elshaug of the Menzies Centre for Health Policy, and agreed to adopt ‘Appropriate Use Criteria’ to guide MBS item review and refinement.

This will mean that from now on clinical committees will adopt a consistent methodology for evaluating MBS items.

The Review requires detailed clinical deliberations and judgements to be properly documented and form the basis for better articulated revisions to MBS item descriptors and fees.

Obsolete items


Thank you to all those who provided comments on the MBS items that clinical committees identified as obsolete.

Your feedback was extremely valuable on the 23 items recommended for removal from the MBS. The clinical committees and the Taskforce have reviewed the feedback, and have made recommendations to Government.



Conferences and presentations


presentation by mbs review chair bruce robinson

Around 40 people from medical colleges and associations received an update on the progress of the MBS Review.

Review Chair Bruce Robinson spoke of how the Taskforce will manage the workload of reviewing over 5,700 items, the vital role of the clinical committees, and the extensive data and evidence reviews already being analysed.

He spoke of the importance of reducing low-value health care to make room within the MBS for high-value care that is to the benefit of patients, and to the health care system more generally.

Throughout 2016 there will be regular consultations and public consultation will follow recommendations from Clinical Committees. That feedback will be considered by the clinical committees and taskforce before recommendations are made.

The Taskforce will continue its engagement across the health sector through a series of stakeholder forums, and through presentations and Q&A sessions at health sector conferences.

If you’d like to hear in more detail about the work of the MBS Review Taskforce, please let us know by emailing the MBS Reviews Unit.

New Clinical Committees announced


The second tranche of Clinical Committees has commenced their work and were welcomed by the Taskforce Chair at their formal induction.

The committees are: Cardiac Services; Dermatology, Allergy & Immunology; Endocrinology; Intensive Care and Emergency Medicine; Oncology, and Renal.

Typically the committee’s work will take six to nine months including intensive review, public consultations and recommendations to the Taskforce and Minister.

new clinical committees announced. from left: dr bruce barraclough, prof alan cass, dr richard harper, prof bruce robinson, dr sally mccarthy, dr stephen schumack (prof jonathan serpell attended by phone).

From left: Dr Bruce Barraclough, Prof Alan Cass, Dr Richard Harper, Prof Bruce Robinson, Dr Sally McCarthy, Dr Stephen Schumack (Prof Jonathan Serpell attended by phone).

Cardiac Services


Chair: Dr Richard Harper

Associate Professor Andrew MacIsaac

Dr David Muller

Professor Derek Chew

Professor Tom Marwick

Associate Professor John Atherton

Dr Ruth Arnold

Professor Paul Bannon

Associate Professor Jayme Bennetts

Dr Ian Scott

Professor Mark Harris

Dr Daniel Moses

Ms Karen Carey

Dermatology, Allergy & Immunology


Chair: Dr Stephen Shumack

Dr Elizabeth Willsteed

Dr Phillip Bekhor

Dr David Heyworth-Smith

Professor Morton Rawlin

Dr Joanne Smart

Dr Charles Cope

Mr Adam Friederich


Endocrinology


Chair: Professor Jonathan Serpell

Professor Timothy Davis

Professor Duncan Topliss

Associate Professor Roderick Clifton-Bligh

Professor Stan Sidhu

Dr Christopher Pyke

Mr Peter Malycha

Dr Suzanne Silberberg

Dr Allan Wycherly

Ms Helen Maxwell-Wright

Ms Janne Graham

Intensive Care and Emergency Medicine


Chair: Dr Sally McCarthy

Membership yet to be confirmed



Oncology


Chair: Dr Bruce Barraclough

Dr Liz Kenny

Professor Michael Barton

Professor Christobel Saunders

Ms Maree Bransdon

Dr Bruce Latham

Professor Sandra O'Toole

Associate Professor Roslyn Francis

Dr Elizabeth Marles

Dr Justin Tse

Professor John Zalcberg

Professor David Thomas

Associate Professor Chris Milros

Dr Catherine Mandel

Professor Guy Maddern

Dr Mustafa Khasraw

Dr Phillip Carson

Professor Sanchia Aranda

Mr John Stubbs

Ms Kathy Wells

Professor Bruce Mann

Renal Medicine


Chair: Professor Alan Cass

Ms Alison Marcus

Dr Paul Snelling

Professor Peter Kerr

Associate Professor Martin Gallagher

Professor Matthew Jose

Professor Stephen McDonald

Dr Troy Kay

Dr Amanda Walker

Professor Tim Usherwood

Professor Kirsten Howard

Dr Neil Boudville

Associate Professor Robyn Langham

For more information


If you’d like an update on the work of the MBS Review Taskforce, please let us know by emailing the MBS Reviews Unit or visiting the website.

To subscribe or unsubscribe from this mailing list please email MBSReviews@health.gov.au




Download 20.98 Kb.

Share with your friends:




The database is protected by copyright ©ininet.org 2024
send message

    Main page